Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 7, 2026Reported sale · Form 4Jay S Stout, Chief Technology Officer · $70.9KOpen the filing ↗
- Oct 7, 2026Reported sale · Form 4Jay S Stout, Chief Technology Officer · $51.2KOpen the filing ↗
- Oct 7, 2026Reported sale · Form 4Melanie Gloria, Chief Operating Officer · $71.8KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record6129 flagged findings
Reported transactions (Form 4)80since Apr 1, 2025 · and 2 other holdings
Corporate events (8-K)27since May 15, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-20Department of Justice inquiryrecentOpen filing ↗“…various federal, state and local authorities in addition to the FDA, including but not limited to, Centers for Medicare & Medicaid…”
+1 more passage from the same document
- “…have ordered certain companies to suspend or permanently cease certain transfers out of Europe for allegedly violating the GDPR’s…”
- 2026-05-20merger or acquisition eventrecentOpen filing ↗“…more experience commercializing drugs that have been approved for marketing. Mergers and acquisitions in the…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 612)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 3, 268-K ↗Current report · Shareholder vote results
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Deep Track Capital, LP · 4.5% · event on Jun 30, 26 · amendment
- Aug 6, 2610-Q ↗Quarterly report
- Aug 6, 268-K ↗Current report · Results
- Jul 22, 26DEFA14A ↗Shareholder meeting and votes
- Jul 22, 26DEF 14A ↗Shareholder meeting and votes
Notice of proposed sale · 4 Form 144 filingsshow all 4hide
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 4 ↗Insider transaction
612 filings on record, the oldest from Feb 11, 19.
Listing the 25 most recent filings of the 612 on record.
1611
3 senior executive changes2025show all 3hide
- Nov 21, 25A senior executive left or was appointed8-K 5.02 ↗
- Jul 29, 25A senior executive left or was appointed8-K 5.02 ↗
- Apr 21, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
4 material agreements entered2021 – 2025show all 4hide
- Jan 13, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Sep 28, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 4, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 23, 21Entered a material agreement8-K 1.01 ↗
- Sep 15, 21A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Aug 2, 21Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Jul 13, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 14, 20Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
- Feb 19, 20A senior executive left or was appointed8-K 5.02 ↗
- Dec 20, 19Entered a material agreement+8 more in the same filing8-K 1.01 ↗
- Oct 2, 19Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Aug 26, 19A senior executive left or was appointed8-K 5.02 ↗
- May 15, 19Entered a material agreement+2 more in the same filing8-K 1.01 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Roivant Sciences Ltd.55.9%Dec 12, 25SCHEDULE 13D/A ↗2 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- FMR LLC8.4%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Deep Track Capital, LP4.5%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jun 26, JAY S STOUT filed notice of intent to sell up to $1.5M. That is about 0.02% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $1.8M across 7 trades, between Jun 26 and Jul 23, per their Form 4. Their sales over those 90 days add up to 116% of the amount announced.
View notice (Form 144) ↗+3 more recent notices · 3 with a later sale
- Oct 7, 26Sell$71KJay S StoutChief Technology Officer↗
- Oct 7, 26Sell$51KJay S StoutChief Technology Officer↗
- Oct 7, 26Sell$72KMelanie GloriaChief Operating Officer↗
- Oct 7, 26Sell$43KTuyl Christopher VanChief Legal Officer↗
- Oct 2, 26Sell$120KEric VenkerChief Executive Officer↗
- Sep 23, 26Sell$103KTuyl Christopher VanChief Legal Officer↗
- Aug 28, 26Sell$65KAtul Pande↗
- Aug 20, 26Sell$135KMelanie GloriaChief Operating Officer↗
- Jul 24, 26Sell$60KAtul Pande↗
- Jul 23, 26Sell$263KTiago GiraoChief Financial Officer↗
- Jul 23, 26Sell$111KJay S StoutChief Technology Officer↗
- Jul 8, 26Sell$75KJay S StoutChief Technology Officer↗
There are 18 more transactions in this stretch.
Stock compensation, tax and giftsshow the 10 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Oct 1, 26Compensation$1.3MEric VenkerChief Executive Officer↗
- Oct 1, 26Other$2.9MEric VenkerChief Executive Officer↗
- Aug 28, 26Compensation$13KAtul Pande↗
- Jul 24, 26Compensation$13KAtul Pande↗
- Jul 1, 26Compensation$1.3MEric VenkerChief Executive Officer↗
- Jul 1, 26Other$3.3MEric VenkerChief Executive Officer↗
- Jun 26, 26Compensation$13KAtul Pande↗
- Jun 26, 26Compensation$159KTiago GiraoChief Financial Officer↗
- Jun 26, 26Compensation$271KTuyl Christopher VanChief Legal Officer↗
- Jun 15, 26Compensation$13KAtul Pande↗
The full record holds 304 transactions and goes back to Jan 11, 23.
Its sector and its market
Immunovant Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Immunovant Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Immunovant Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 612 documents on file, from Feb 11, 2019 to Oct 9, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.